ArticlePDF Available

The Triple Aim: Care, Health, and Cost

Authors:

Abstract

Improving the U.S. health care system requires simultaneous pursuit of three aims: improving the experience of care, improving the health of populations, and reducing per capita costs of health care. Preconditions for this include the enrollment of an identified population, a commitment to universality for its members, and the existence of an organization (an "integrator") that accepts responsibility for all three aims for that population. The integrator's role includes at least five components: partnership with individuals and families, redesign of primary care, population health management, financial management, and macro system integration.
TheTripleAim:Care,Health,
And Cost
The remaining barriers to integrated care are not technical; they are
political.
by Donald M. Berwick, Thomas W. Nolan, and John Whittington
ABSTRACT: Improving the U.S. health care system requires simultaneous pursuit of three
aims: improving the experience of care, improving the health of populations, and reducing
per capita costs of health care. Preconditions for this include the enrollment of an identi-
fied population, a commitment to universality for its members, and the existence of an or-
ganization (an “integrator”) that accepts responsibility for all three aims for that population.
The integrator’s role includes at least five components: partnership with individuals and
families, redesign of primary care, population health management, financial management,
and macro system integration. [Health Affairs 27, no. 3 (2008): 759–769; 10.1377/hlthaff
.27.3.759]
Congestive heart failure (CHF) is the most common reason for ad-
mission of Medicare patients to a hospital.1Sadly, 40 percent of Medicare
patients discharged after admission for CHF are readmitted within ninety
days, even though well-designed demonstration projects have shown for years that
that rate can be reduced by more than 80 percent with proper management of pa-
tients.2Patients experience this reactive system as one providing poor service and
lacking memory. Caregivers experience frustration, despite their best efforts.
nU.S. health system scorecard. CHF care is not an isolated case. It is a prime
example of what goes wrong when a health care system lacks the capacity to inte-
grate its work over time and across sites of care. The recent “Scorecard” from the
Commonwealth Fund Commission on a High Performance Health System gives the
U.S. health care system an overall score of 66 percent, with 100 percent referring to
the top decile of known performance.3The commission notes that even though U.S.
health care expenditures are far higher than those of other developed countries, our
results are no better. Despite spending on health care being nearly double that of the
next most costly nation, the United States ranks thirty-first among nations on life
expectancy, thirty-sixth on infant mortality, twenty-eighth on male healthy life ex-
pectancy, and twenty-ninth on female healthy life expectancy.4As a side effect of the
Tr i p l e A i m
HEALTH AFFAIRS ~ Volume 27, Number 3 759
DOI 10.1377/hlthaff.27.3.759 ©2008 Project HOPE–The People-to-People Health Foundation, Inc.
Donald Berwick (dberwick1@ihi.org ) is president and chief executive officer of the Institute for Healthcare
Improvement (IHI) in Cambridge, Massachusetts. Thomas Nolan is a senior fellow at IHI in Silver Spring,
Maryland. John Whittington is a senior fellow at IHI in Cambridge.
cost burden, the United States is the only industrialized nation that does not guar-
antee universal health insurance to its citizens. We claim we cannot afford it.
nCare improvement efforts. Most recent efforts to improve the quality of
health care have aimed to reduce defects in the care of patients at a single site of care
in all six dimensions identified by the Institute of Medicine (IOM): safety, effective-
ness, patient-centeredness, timeliness, efficiency, and equity.5Slow progress in each
of these is occurring, as measurements, incentives, knowledge, will, and experi-
ments come increasingly into alignment. However, the task of improving individu-
als’ care is hardly completed. In the wave of projects on “pay-for-performance” (P4P)
and public reporting, policymakers, payers, and health care leaders are still strug-
gling to make highly reliable and safe health care a norm rather than an exception.6
Moreover, too few improvement efforts address defects in care across the contin-
uum, such as those that plague patients with CHF.
Defining The “Triple Aim”
Work to improve site-specific care for individuals should expand and thrive. In
ourview,however,theUnitedStateswillnotachievehigh-valuehealthcareun-
less improvement initiatives pursue a broader system of linked goals. In the aggre-
gate, we call those goals the “Triple Aim”: improving the individual experience of
care; improving the health of populations; and reducing the per capita costs of care
for populations.
nInterdependent goals. The components of the Triple Aim are not independ-
ent of each other. Changes pursuing any one goal can affect the other two, sometimes
negatively and sometimes positively. For example, improving care for individuals
can raise costs if the improvements are associated with new, effective, but costly
technologies or drugs. Conversely, eliminating overuse or misuse of therapies or di-
agnostic tests can lead to both reduced costs and improved outcomes. The situation
is made more complex by time delays among the effects of changes. Good preventive
care may take years to yield returns in cost or population health.
nAn exercise in balance. Pursuit of the Triple Aim is an exercise in balance
and will be subject to specified policy constraints, such as decisions about how
much to spend on health care or what coverage to provide and to whom. The most
important of all such constraints, we believe, should be the promise of equity; the
gain in health in one subpopulation ought not to be achieved at the expense of an-
other subpopulation. But that decision lies in the realms of ethics and policy; it is not
technically inherent in the Triple Aim.
A health system capable of continual improvement on all three aims, under
whatever constraints policy creates, looks quite different from one designed for
the first aim only. The balanced pursuit of the Triple Aim is not congruent with
the current business models of any but a tiny number of U.S. health care organiza-
tions. For most, only one, or possibly two, of the dimensions is strategic, but not
all three. Thus, we face a paradox with respect to pursuit of the Triple Aim. From
760 May/June 2008
Quality & Accountability
the viewpoint of the United States as a whole, it is essential; yet from the view-
point of individual actors responding to current market forces, pursuing the three
aims at once is not in their immediate self-interest.
Take hospitals as an example. Under current market dynamics and payment in-
centives, it is entirely rational for hospitals to try to fill beds and to expand ser-
vices even though the work of Elliott Fisher and John Wennberg strongly predicts
the net effect to be much higher cost and no higher quality.7Most hospitals seem
to believe that they can protect profits best by protecting and increasing revenues.
Higher efficiency in local production can help, too, but systemic efficiencies that
reduce revenues or admission rates are threats to profit. The same payment dy-
namics often lead hospitals to focus only on care within their walls, viewing CHF
readmissions, for example, as indicating defects outside the hospital, not as their
responsibility to avert.
nA “tragedy of the commons.” Rational common interests and rational indi-
vidual interests are in conflict. Our failure as a nation to pursue the Triple Aim
meets the criteria for what Garrett Harden called a tragedy of the commons.”8As in
all tragedies of the commons, the great task in policy is not to claim that stake-
holders are acting irrationally, but rather to change what is rational for them to do.
The stakes are high. Indeed, the Holy Grail of universal coverage in the United States
may remain out of reach unless, through rational collective action overriding some
individual self-interest, we can reduce per capita costs.
nObstaclestopursuitoftheTripleAim.The changes we would need to mobi-
lize pursuit of the Triple Aim are large, and the obstacles are daunting. Among the
biggest barriers are supply-driven demand; new technologies including many with
limited impact on outcomes; physician-centric care; little or no foreign competition
to spur domestic change, as it does in manufacturing; and too little appreciation of
system knowledge among clinicians and organizations, leading them to subopti-
mize the components of the system with which they are most familiar, at the ex-
pense of the whole.
nPromising innovations. Despite these obstacles, a handful of innovators are
starting to challenge the U.S. health care market. These disruptive innovations are
by no means yet mainstream, but the examples align surprisingly well with the
objectives of the Triple Aim. For example, innovations in primary care such as the
medical home, as well as “Minute Clinics” and other retail health care providers are
challenging the prevailing approach to primary care.9Experiments in telecommuni-
cations are offering care that is no longer location-specific.10 One form of foreign
competition—“medical tourism”—is beginning to catch on. Also, a few hospitals,
such as Virginia Mason Medical Center, Denver Health, and ThedaCare, are learning
Tr i p l e A i m
HEALTH AFFAIRS ~ Volume 27, Number 3 761
“The Holy Grail of universal coverage may remain out of reach
unless we can reduce per capita costs.”
tousesystemsknowledgetoreducecostsandimproveprofit,suchasbyadapting
“lean production” to health care.11
nMeasuring health care quality. In general, opacity of performance is not a
major obstacle to the Triple Aim. Many tools are in hand to construct part of a bal-
anced portfolio of measures to track the experience of a population on all three com-
ponents. At the Institute for Healthcare Improvement (IHI), for example, we have
developed and are using a balanced set of systemwide measures closely related to the
Triple Aim.12 A more complete set of system metrics would include ways to track the
experience of care in ambulatory settings, including patient engagement, continuity,
and clinical preventive practices.
nMeasuring costs and health status. Measuring per capita costs is still a big
challenge; it requires that we capture all relevant expenditures, index them appro-
priately to local market circumstances, and be able to measure actual costs in a care
system whose current methods of pricing and discounting obscure them. Popula-
tion health measures would require some form of registration or sampling for de-
fined populations and would be speeded by widespread implementation of elec-
tronic health record systems. Citing one serious gap, the IOM recently concluded
that measures of both cost and care across the continuum, impeded by the fragmen-
tation of delivery itself, still need much more developmental work.
Preconditions For Pursuit Of The Triple Aim
Despite the social need and the feasibility of measurement, actual pursuit of the
Triple Aim remains the exception. What would be the preconditions for changing
that?
We suggest that three inescapable design constraints underlie effective accom-
plishment of the Triple Aim: (1) recognition of a population as the unit of concern,
(2) externally supplied policy constraints (such as a total budget limit or the re-
quirement that all subgroups be treated equitably), and (3) existence of an inte-
grator” able to focus and coordinate services to help the population on all three
dimensions at once.
nSpecifying a population of concern. A “population” need not be geographic.
What best defines a population,asweusetheterm,isprobablytheconceptofenroll
-
ment. (This is different from the prevailing meaning of the word enrollment in U.S.
health care today, which denotes a financial transaction, not a commitment to a
healing relationship.) A registry that tracks a defined group of people over time
would create a population” for the purposes of the Triple Aim. Other examples of
populations are “all of the diabetics in Massachusetts,” people in Maryland below
300 percent of poverty,” “members of Group Health Cooperative of Puget Sound,”
“the citizens of a county,” or even “all of the people who say that Dr. Jones is their
doctor.” Only when the population is specified does it become, in principle, possible
to know about its experiences of care, its health status, and the per capita costs of
caring for it. Under current conditions, such registries are rare in the United States,
762 May/June 2008
Quality & Accountability
especially for geographically defined populations. Creating them will require re-
search, development, and investment.
nPolicy constraints. Thepolicyconstraintsthatshapethebalancesought
among the three aims are not automatic or inherent in the idea. Rather, they derive
from the processes of decision making, politics, and social contracting relevant to
the population involved. For example, a nation or state might or might not decide
that universal coverage” is mandatory; a community in a town meeting or an em-
ployer in negotiation with a labor union might or might not decide to spend no more
than xdollars per capita or ydollars per year on health care. Logically—that is,
mathematically—optimizing on three aims at once requires constraints on at least
two of them.
nIntegrator. An “integrator” is an entity that accepts responsibility for all three
components of the Triple Aim for a specified population. Importantly, by definition,
an integrator cannot exclude members or subgroups of the population for which it is
responsible. The simplest such form, such as Kaiser Permanente, has fully integrated
financing and either full ownership of or exclusive relationships with delivery struc-
tures, and it is able to use those structures to good advantage. We believe, however,
that other models can also take on a strong integrator role, even without unified fi-
nancing or a single delivery system. That role might be within the reach of a power-
ful, visionary insurer; a large primary care group in partnership with payers; or even
a hospital, with some affiliated physician group, that seeks to be especially attractive
to payers.
In crafting care, an effective integrator, in one way or another, will link health
care organizations (as well as public health and social service organizations)
whose missions overlap across the spectrum of delivery. It will be able to recog-
nize and respond to patients’ individual care needs and preferences, to the health
needs and opportunities of the population (whether or not people seek care), and
to the total costs of care. The important function of linking organizations across
the continuum requires that the integrator be a single organization (not just a
market dynamic) that can induce coordinative behavior among health service
suppliers to work as a system for the defined population.
Functions Of An Integrator
nInvolving individuals and families. Pursuit of the Triple Aim requires that the
population served become continually better informed about both the determinants
of their own health status and the benefits and limitations of individual health care
practices and procedures. An effective integrator would work persistently to change
the “more-is-better” culture through transparency, systematic education, communi-
cation, and shared decision making with patients and communities, rather than by
restricting access, shifting costs, or erecting administrative hurdles to care. Many
members of the population, especially those with chronic illnesses, will need some-
one who can work with them to establish a plan for their ongoing care, guide them
Tr i p l e A i m
HEALTH AFFAIRS ~ Volume 27, Number 3 763
through the technological jungle of acute care, advocate for them, and interpret.
nRedesign of primary care services and structures. We believe that a ny ef-
fective integrator will strengthen primary care for the population. To accomplish
this, physicians might not be the sole, or even the principal, providers. Recently, phy-
sicians and other clinicians have proposed principles for expanding the role of pri-
mary care under the title of the medical home. This expanded role includes estab-
lishing long-term relations between patients and their primary care team;
developing shared plans of care; coordinating care, including subspecialists and hos-
pitals; and providing innovative access to services through improved scheduling,
connection to community resources, and new means of communication among indi-
viduals, families, and the primary care team facilitated by a patient-controlled per-
sonalized health record. The integrator would assume responsibility for building
the capability and infrastructure to enable primary care practices to function in this
expanded role.
nPopulation health management. The integrator would be responsible for
deploying resources to the population, or for specifying to others how resources
should be deployed. Segmentation of the population, perhaps according to health
status, level of support from family or others, and socioeconomic status, will facili-
tate efficient and equitable resource allocation.13 The growing availability of high-
quality health information on the Internet will help all segments manage their own
care and understand options for treatment.
Today’s individual health care processes are designed to respond to the acute
needs of individual patients, rather than to anticipate and shape patterns of care
for important subgroups. An integrator would act differently, assigning much
more value and many more resources, for example, to the monitoring and intercep-
tion of early signs of deterioration among the 100 CHF patients in a doctor’s panel
or the 1,000 CHF patients who used the hospital last year.
Famously, the “actual” causes of mortality in the United States lie in behavior
that the individual health care system addresses unreliably or not at all, such as
smoking, violence, physical inactivity, poor nutrition, and unsafe choices.14 An in-
tegrator would increase preventive efforts. An integrator would also encourage
and cooperate with governmental policies, agencies, and programs to discourage
smoking, combat obesity, provide alternatives to violence and substance abuse,
and address community determinants of mental health problems.
nFinancial management system. The broken financing system of the present
mirrors the fragmented care system. An effective integrator would assure that pay-
mentandresourceallocationsupporttheTripleAim.Animportantfirststepfora
systems approach to cost control would be defining, measuring, and making trans-
parent the per capita cost of care for a defined population. For example, companies
could begin to show on employees’ paychecks the amount of money spent per em-
ployee by the company to provide health insurance. The Centers for Medicare and
Medicaid Services (CMS) could provide regions with cost information per benefi-
764 May/June 2008
Quality & Accountability
ciary to allow comparisons of costs and inflation across the country.
A mainstay of reduction and control of per capita costs would be yearly initia-
tives to reduce waste in all of its forms, especially procedures, tests, and visits that
represent rework, errors, unscientific care, or otherwise valueless services. George
Isham, medical director of HealthPartners in Minneapolis, has called for a project
to identify the ten most common forms of waste in each medical specialty.15 Any
integrator collaborating on improvement of value with its suppliers of specialty
care would be very interested in Isham’s list. An indication of progress on the Tri-
ple Aim would be doctors’ leading and energetically participating in such efforts.
Perhaps the most powerful needed change is to disrupt the dynamics of supply-
driven care and instead to match supply better to underlying needs. An integrator
would approach new technologies and capital investments with skepticism and
require that a strong burden of proof of value lie with the proponent. Operating
budgets would encourage thinking across boundaries. An integrator would ask,
MighttwoadditionalhomeoutreachnursesbebetterfortheTripleAimthanan
-
other cardiologist?” Capital budgets would be informed by the insights of Fisher
and Wennberg, and good integrators would encourage through incentives—and,
if needed, regulations—strict limits on the growth of facilities.
The hallmarks of proper financial management in a system pursuing the Triple
Aim, we suspect, are government policies, purchasing contracts, or market mech-
anisms that lead to a cap on total spending, with strictly limited year-on-year
growth targets.
nSystem integration at the macro level. A conscientious integrator would as-
pire to produce or contract for individual care and population-based interventions
that are evidence-based and highly reliable. To achieve that, all in the system of care
would need access to up-to-date medical knowledge, standardized definitions of
quality and cost, and evidence and measurement collected and distributed by a thor-
oughly trustworthy body. In effect, patients, caregivers, organizations, and manag-
ers would know the “state of the system with respect to its reliability, adherence to
evidence, cost, and progress in improvement.
In most cases, the integrator would not be a direct provider of all necessary ser-
vices. Instead, it would need to commission some services from suppliers through
business relationships consciously designed to facilitate pursuit of the Triple Aim.
Michael Porter and Elizabeth Teisberg have called for a redefinition of competi-
tion in health care.16 They assert that value is added by care that produces the best
outcomes at the lowest cost over time. An integrator, following their logic, might
contract with a multifunctional group of providers to serve a specific subpopula-
tion.
Precedents And Possibilities
The Triple Aim is far from a totally new idea. As one would expect, organiza-
tions and other stakeholders in a variety of countries that begin with a population
Tr i p l e A i m
HEALTH AFFAIRS ~ Volume 27, Number 3 765
in mind tend to want to achieve all three goals at once. Among these stakeholders
are (1) government-sponsored or -owned health care systems that have legally
chartered duties to defined populations and that own facilities, employ clinicians,
and provide and manage clinical services (in the United States, these include the
Veterans Health Administration, the Indian Health Service, and the Military
Health Command); (2) classical staff- and group-model health maintenance orga-
nizations (HMOs), such as Kaiser Permanente, HealthPartners, and Group Health
CooperativeofPugetSound,whichcombineinsuranceandcaredeliveryfunc
-
tions (although usually not public health systems) for enrolled populations; and
(3) national and other governmental health care systems that aggregate tax reve-
nues into global budgets and, through employment, ownership, and contracting,
ensure care for populations. Examples include the National Health Service (NHS)
in the United Kingdom and health care in Sweden, where counties act as integra-
tors, using general tax revenues to fund the comprehensive care systems that
county-level executives organize and improve for their entire population.17
In the United States, a few additional cases of Triple Aim–oriented organiza-
tions have emerged. Some employers, fed up with out-of-control costs but unwill-
ing to give up trying to ensure proper care for their employees, have started their
own care systems, reminiscent of the roots of Kaiser Permanente. For example,
QuadGraphics,alargeU.S.publishingcompany,startedQuadMed,awholly
owned subsidiary that provides care to QuadGraphics employees using a highly
innovative model of strong primary care as the mainstay.18
Occasional entrepreneurial hospital-based systems, often with very high mar-
ket share and strong community roots, such as Intermountain Health Care,
Geisinger Health System, Bellin Health System, and (for care of the underserved)
Denver Health, try to knit together components of the care system in virtual ag-
gregates through technical support and innovative contracts. The numerous re-
cent state-level initiatives for universal health insurance coverage inevitably face
theTripleAimastheonlyroutetoaffordability;Massachusetts,asoneexample,
has established a Quality and Cost Council to try to determine how to keep all
three aims in a single field of vision.19
nHMOs as integrators. So what happened to HMOs? As conceived by their
greatest champion, Paul Ellwood, HMOs were, or were intended to be, integrators
exactlyaswepropose,inpursuitoftheTripleAim.
20 On closer inspection, the HMO
movement was eventually defined by its organizational structure rather than its
aims and performance. The experience of people enrolled in HMOs was not suffi-
ciently improved to overcome the restriction of choice of providers or the perceived
barriers to access to specialists that became part of the HMO model. Because they
restricted care, HMOs were vulnerable to competitive retaliation by indemnity in-
surers and others, which began offering products called “HMO” or “managed care”
that merely managed money, not care. Furthermore, proponents of HMOs might
have overestimated the cost-saving potential of proper preventive care, instead of
766 May/June 2008
Quality & Accountability
viewing population health status and per capita cost control as separate aims.21 Fi-
nally, HMOs were competing for doctors and acute care suppliers in an environment
in which these providers were in control of demand and thus revenue. The HMO
was not an attractive business alternative for them.
nEncouraging signs for integrated care. Even with the similarity between an
HMO and our view of the integrator, we are encouraged in large measure because
thepossibilitiesofintegratedcarehavesothoroughlychangedwiththeadventof
electronic support systems and the possibilities for virtual integration and instant
communication that were unimaginable when HMOs were first described. Fisher’s
recent proposals for virtual integration of care through extended medical staffs, for
example, represent innovations that draw on some of the principles of classical
HMOs, but with entirely new processes and relationships at their core.22 Innova-
tions in payment design, such as bundled payment experiments by the CMS for
chronic disease management and Harold Luft’s conceptualization of case rates for
local microsystems, offer interesting approaches to encouraging integrated behavior
without the managerial superstructure of an HMO.23
nWhat it takes to progress toward integrated care. From the (we hope tem-
porary) failure of the best features of the HMO concept we take the lesson not that
all integrated care is destined to fail, but rather that pursuit of the Triple Aim threat-
ens the U.S. status quo health care system. The current behavior, destructive of the
Triple Aim and inimical to the best aspects of sound, managed care, is a predictable,
indeed inevitable, consequence of the current rules. If we want different behavior,
we will need new financing and competitive dynamics. What new financing or dy-
namics, different from today’s, would lead rational hospitals to try to reduce re-
admissions dramatically for CHF?
If we could ever find the political nerve, we strongly suspect that financing and
competitive dynamics such as the following, purveyed by governments and pay-
ers, would accelerate interest in the Triple Aim and progress toward it: (1) global
budget caps on total health care spending for designated populations, (2) mea-
surement of and fixed accountability for the health status and health needs of des-
ignated populations, (3) improved standardized measures of care and per capita
costs across sites and through time that are transparent, (4) changes in payment
such that the financial gains from reduction of per capita costs are shared among
those who pay for care and those who can and should invest in further improve-
ments, and (5) changes in professional education accreditation to ensure that cli-
nicians are capable of changing and improving their processes of care. With some
risk, we note that the simplest way to establish many of these environmental con-
ditions is a single-payer system, hiring integrators with prospective, global bud-
Tr i p l e A i m
HEALTH AFFAIRS ~ Volume 27, Number 3 767
“Innovations in payment design encourage integrated behavior
without the managerial superstructure of an HMO.”
gets to take care of the health needs of a defined population, without permission
to exclude any member of the population.
Indicators Of Progress
In our lighter moments, we have tried to imagine the most elegant possible “Tri-
ple Aim Test,” asking, “How would we know at first glance that the care for a pop-
ulation is actually making progress on the Triple Aim?” Our proposed test has only
three items. First, hospitals involved in the Triple Aim would be trying to be emp-
tier, not fuller. They would celebrate as success that the hospital is less and less of-
ten needed by the population. Second, Fisher and Wennberg would be happier.
They would observe that the dynamics of supply-driven care are no longer strong
and that patients pull resources, rather than vice versa. And third, patients would
say of those who try to maintain and restore their health: “They remember me.”
They would recognize that the health care system is mindful of their needs, wants,
and opportunities for health even when they themselves forget. Health care would
also be mindful that people have excellent uses for their wealth other than paying
for care they do not need or for illnesses they could have avoided.
Whether or not the triple aim is within reach for the United
States has become less and less a question of technical barriers. From
experiments in the United States and from examples of other coun-
tries, it is now possible to describe feasible, evidence-based care system designs
that achieve gains on all three aims at once: care, health, and cost. The remaining
barriers are not technical; they are political. The superiority of the possible end
state is no longer scientifically debatable. The pain of the transition state—the
disruption of institutions, forms, habits, beliefs, and income streams in the status
quo—is what denies us, so far, the enormous gains on components of the Triple
Aim that integrated care could offer.
TheauthorsaregratefulforthecontributionsofJaneRoessner, Frank Davidoff, Val Weber, Samantha Henderson,
and Maureen Bisognano.
NOTES
1. H.M. Krumholz et al., ”Readmission after Hospitalization for Congestive Heart Failure among Medicare
Beneficiaries,” Archives of Internal Medicine 157, no. 1 (1997): 99–104.
2. G.C. Fonarow et al., “Impact of a Comprehensive Heart Failure Management Program on Hospital Read-
mission and Functional Status of Patients with Advanced Heart Failure,” Journal of the American College of
Cardiology 30, no. 3 (1997): 725–732.
3. J.C. Cantor et al., “Aiming Higher: Results from a State Scorecard on Health System Performance” (New
York: Commonwealth Fund, June 2007); and Commission on a High Performance Health System, “Why
Not the Best? Results from a National Scorecard on U.S. Health System Performance” (New York: Com-
monwealth Fund, September 2006).
4. World Health Organization, “World Health Statistics 2006,” http://www.who.int/whosis/whostat2006/
en (accessed 28 June 2007).
5. Institute of Medicine, Crossing the Quality Chasm: A New Health System for the Twenty-first Century (Washington:
National Academies Press, 2001).
768 May/June 2008
Quality & Accountability
6. “CMS/Premier Hospital Quality Incentive Demonstration (HQID),” http://www.premierinc.com/quality-
safety/tools-services/p4p/hqi/index.jsp (accessed 28 June 2007).
7. E.S. Fisher et al., The Implications of Regional Variations in Medicare Spending, Part 1: The Content,
Quality, and Accessibility of Care,” Annalsof Internal Medicine 138, no. 4 (2003): 273–287; and E.S. Fisher et al.,
“The Implications of Regional Variations in Medicare Spending, Part 2: Health Outcomes and Satisfaction
with Care,” Annals of Internal Medicine 138, no. 4 (2003): 288–298.
8. G. Hardin, “The Tragedy of the Commons,” Science 162, no. 5364 (1968): 1243–1248; and H.H. Hiatt, “Pro-
tecting the Medical Commons: Who Is Responsible?” New England Journal of Medicine 293, no. 5 (1975): 235–
241.
9. American Academy of Family Physicians et al., “Joint Principles of the Patient-Centered Medical Home,”
March 2007, http://www.medicalhomeinfo.org/Joint%20Statement.pdf (accessed 30 January 2008); and
California HealthCare Foundation, Health Care in the Express Lane: The Emergence of Retail Clinics, July 2006,
http://www.chcf.org/documents/policy/HealthCareInTheExpressLaneRetailClinics.pdf (accessed 30 Jan-
uary 2008).
10. J.H. Stone, “Communication between Physicians and Patients in the Era of E-Medicine,” New England Jour-
nal of Medicine 356, no. 24 (2007): 2451–2454.
11. P.M. Carrera, “Medical Tourism” (Letter to the Editor), Health Affairs 25, no. 5 (2006): 1453; and IHI, “Going
Lean in Health Care,” IHI Innovation Series White Paper, 2005, http://www.ihi.org/IHI/Results/White
Papers/GoingLeaninHealthCare.htm (accessed 23 October 2007).
12. L.A. Martin et al., “Whole System Measures, IHI Innovation Series White Paper, 2007, http://www.ihi
.org/IHI/Results/WhitePapers/WholeSystemMeasuresWhitePaper.htm (accessed 23 October 2007).
13. J. Lynn et al., “Using Population Segmentation to Provide Better Health Care for All: The ‘Bridges to
Health’ Model,” Milbank Quarterly 85, no. 2 (2007): 185–208.
14. J.M. McGinnis and W.H. Foege, “Actual Causes of Death in the United States,” Journal of the American Medical
Association 270, no. 18 (1993): 2207–2212; and A.H. Mokdad et al., “Actual Causes of Death in the United
States, 2000,” Journal of the American Medical Association 291, no. 10 (2004): 1238–1245.
15. G. Isham, TheRichard and Hinda Rosenthal Lectures 2005: Next Steps toward Higher Quality Health Care (Washington:
National Academies Press, 2006).
16. M. Porter and E. Teisberg, Redefining Health Care: Creating Value-Based Competition on Results (Boston: Harvard
Business School Press, 2006).
17. B. Andersson-Gäre and D. Neuhauser, “The Health Care Quality Journey of Jonkoping County Council,
Sweden,” Quality Management in Health Care 16, no. 1 (2007): 2–9.
18. V. Fuhrmans, “One Cure for Health Costs: In-House Clinics at Companies,” Wall Street Journal, 11 February
2005.
19. J. Holahan and L. Blumberg, “Massachusetts Health Care Reform: A Look at the Issues,” Health Affairs 25
(2006): w432–w443 (published online 14 September 2006; 10.1377/hlthaff.25.w432).
20. P.M. Ellwood et al., “Health Maintenance Strategy,” Medical Care 9, no. 3 (1971): 291–298.
21. L.B. Russell, Evaluating Preventive Care: Report on a Workshop (Washington: Brookings Institution, 1987).
22. E.S. Fisher, “2007 Robert and Alma Moreton Lecture: Pay for Performance: More than Rearranging the
Deck Chairs,” Journal of the American College of Radiology 4, no. 12 (2007): 879–885.
23. Centers for Medicare and Medicaid Services, “Advisory Board on the Demonstration of a Bundled Case-
Mix Adjusted Payment System for End Stage Renal Disease (ESRD) Services,” September 2007, http://
www.cms.hhs.gov/FACA/09_AdvisoryBoardontheDemoofPaymentSystemfor(ESRD)Services.asp (ac-
cessed 23 October 2007); and H.S. Luft, Universal Health Care Coverage: A Potential Hybrid Solution,”
Journal of the American Medical Association 297, no. 10 (2007): 1115–1118.
Tr i p l e A i m
HEALTH AFFAIRS ~ Volume 27, Number 3 769
... Furthermore, many studies incorporate program theory that outlines the goals and proposed mechanisms for why a specific intervention is expected to be effective, both regarding health-related outcomes as well as system efficiency, for instance through shifting inpatient to outpatient care. [38,47,48]. ...
... A related strength of the review is the inclusion of studies reporting both health care utilization and health related outcomes, generating a broad picture of the effects of IOC in comparison to reviews focusing on single outcomes as well being in better alignment with the goals of coordinated care [40,47]. Furthermore, this systematic review has the advantage of including articles with relatively strong study designs with comparatively low risk of bias in comparison to studies included in other reviews [6]. ...
Article
Full-text available
Introduction: Health and social care systems are constantly undergoing major reforms to meet the rising demands of an increasing proportion of older patients, with many such reforms aiming to improve integration and coordination. The aim of this systematic review was to synthesize the evidence on inter-organizational coordination interventions between hospitals and outpatient (health- and social care) providers for older patients with complex needs during- and after hospital discharge. Methods: A systematic search of four databases was performed to identify interventions of inter-organizational coordination at hospital discharge for older patients with complex needs. The retrieved literature was analyzed using a narrative synthesis. Results: Twelve studies were included (seven randomized controlled trials and five non-randomized intervention studies). The most common intervention components were; needs assessments, dedicated care coordinators and multi-professional teams. Findings show that inter-organizational coordination could decrease- or even increase readmission rates, with similar findings for hospital length of stay and mortality. Furthermore, inter-organizational coordination seemed to have a positive impact on quality of life and activities of daily living. Conclusion: Inter-organizational coordination could potentially reduce health-care utilization and improve quality of life for older patients with complex needs. However, the findings remain uncertain and further research is warranted.
... The desire to overcome inefficiency and to ensure that the healthcare provided is effective, safe and appropriate is inherent in the ethos of a public health system. There is general recognition that unless wastage of resources and provision of ineffective or inappropriate care can be eliminated, it will not be possible to have an equitable, affordable and sustainable healthcare system [15][16][17]. This does necessitate developing methods to ascertain whether performance is meeting expectations and aspirations. ...
Article
Full-text available
Purpose – The paper explores the concept of performance measurement and identifies that when measurement information does not inform about the performance of the system, it is not used and the effort becomes wasteful. Strategies to make performance measurement and reporting more meaningful are identified. Design/methodology/approach – The paper explores concepts and relevant and selected literature to understand the measurement of performance and how to make it meaningful. Some strategies to make measurement and reporting of performance meaningful are suggested. Findings – The process of collection and use of performance measures is resource-intensive. If this information is then not used appropriately and fully, it can become a considerable waste. Healthcare system performance measurement is complex. These complexities include the fact that outputs or deliverables may not be able to inform the strategic objectives. The package of care has to be customised to the needs of the consumer, and therefore, measures of effectiveness are difficult to pre-determine. Morevore, measures are often interrelated, and one measure by itself may not inform about the performance of the system. Research limitations/implications – Complex systems have many variables that are interdependent. Even though this conceptual paper explores the measurement of system performance, it has to be acknowledged that specific interdependencies between performance variables for each complex system have to be understood to determine the relevance of measures of performance for each specific system. Practical implications – The paper describes ways in which performance measurement information can be reported to make it more meaningful and value-adding for the organisation. Visualisation of measures of performance should be customised for specific stakeholders to retain their interest. However, it must also be acknowledged that visualisation without an opportunity for analysis makes visualisation non-value-adding.
... IPC has been heralded as an effective way to provide patient-centred care [2], which implies that patients are the ultimate beneficiaries of IPC. Therefore, it is important to study patients' experience of IPC [3]. ...
Article
Full-text available
Introduction Patient experience of interprofessional collaboration in primary care has been well-studied but not in specialist clinics. Our qualitative study aimed to understand patients’ experience of a nurse-doctor collaboration at three specialist clinics (Epilepsy Clinic, Neuroimmunology Clinic, and Persistent Concussion Clinic) in a tertiary neurology care centre in Singapore. Methodology Between December 2023 and April 2024, participants of different demographic and disease profiles from the three specialist clinics were recruited using maximum variation selection. We generated observation and interview data to understand patient experience in a multifaceted and in-depth manner. We analyzed the data using Braun and Clarke’s reflexive thematic analysis. Results We observed 27 patients, of whom 12 agreed to be interviewed. We constructed two themes. The first discussed the patients’ varied receptivity to interprofessional collaboration depending on their perceived healthcare needs. Most patients valued collaborative care as it saved time and enhanced their access to psychosocial and financial support. However, patients whose disease status was still active preferred to consult the doctors for symptomatic management through drug treatment. They were observed to be reticent about sharing their preference with the care team. The second theme examined the absence of formal introduction of the concept of interprofessional collaboration to the patients. Some patients appeared to be unaware that specialist nurses were qualified to collaborate with doctors, and this lowered their perceptions of the nurses’ competence and seemingly weakened their receptivity to IPC. Conclusion Patients’ experience of IPC at specialist clinics varied depending on patients’ perceived healthcare needs. To optimize patients’ receptivity to IPC, the provision of collaborative care should be calibrated to fulfill different patients’ perceived and actual healthcare needs. Doing so may optimize the value of collaborative care to patients. Further enhancements to patients’ receptivity would involve the intentional effort to prepare patients for collaborative practice.
... Moreover, it accommodates access-related indicators, which are central to rural-urban analyses. Alternative frameworks such as the Institute for Healthcare Improvement's "Triple Aim [29]" were considered; however, they emphasize population-level goal-setting rather than the indicator-level mapping required for this scoping review. We operationalized the three domains as follows: (i) Structure = provider, facility, or system attributes (e.g., physician-to-population ratio); (ii) Process = care activities including adherence to guidelines or timeliness (e.g., door-to-balloon time); (iii) Outcome = patient-level or population-level results (e.g., mortality, life expectancy). ...
Article
Full-text available
Background The rural-urban disparity in healthcare quality is a global issue. Compared with living in urban areas, living in rural areas is associated with poorer healthcare outcomes. Moreover, the shortage of healthcare providers in rural areas is a worldwide concern. This scoping review aims to map existing evidence regarding rural-urban disparities in access and quality of healthcare in Japan using the Donabedian model as a theoretical framework and to identify conceptual and measurement gaps. Methods This review targeted published articles and gray literature. We included documents that (1) were based on Japanese populations and (2) compared the quality of care between defined rural and urban areas. We excluded articles if they (1) were published during or before 2005 since the Japanese government amended the Medical Care Law in 2006; (2) focused exclusively on urban or rural areas; or (3) were not published in English or Japanese. This study employed PubMed, EMBASE, Web of Science, the Japanese medical literature database, ICHUSHI, and CiNii Research. We extracted quality indicators (structure, process, and outcomes) based on the Donabedian model. We recorded the definitions or indicators of rurality described by the studies. Results Out of 5,020 articles, 15 were included. Only one study was conducted in a primary care setting. Moreover, no study evaluated the “outcomes” of the Donabedian model in a primary care setting. Regarding the definitions or indices of rurality, the most commonly used indicator of rurality was population size, followed by population density. The cutoff values or descriptions of rurality using these indicators differed across studies. Conclusion This study mapped rural-urban disparities in access and quality of healthcare in Japan. These findings highlight the need to evaluate rural-urban disparities in the “outcomes” of care in primary care settings in Japan and the lack of common indicators of rurality.
Article
Background Exploring the “wicked” problem of improving care for patients with complex care needs could benefit a large swath of health system stakeholders given the breadth and depth of this issue. Patients with complex health and social needs often require customized care that deviates from expected care trajectories. At Canadian Stroke Distinction sites, clinicians provide care for a high proportion of patients with complex needs while adhering to best practice recommendations. Methods We conducted an interpretive description study, which explored the perspectives of 16 stroke rehabilitation clinicians, four organizational key informants, and two health system key informants. We collected data via 45- to 60-minute virtual interviews and engaged in a hybrid inductive–deductive approach to analysis. Results We constructed three main themes: (a) recognizing complexity is routine work for clinicians, (b) clinicians use workarounds to manage complexity, and (c) clinicians perceived and worked to bridge a difference between organizational processes and the realities of patient care. When comparing clinician and key informant perspectives, we noted differences regarding their perceptions of the prevalence and nature of patient complexity. We developed the concept of “work-as-expected” as an intermediary to bridge the gap between the “work-as-imagined” and “work-as-done” framework. Conclusion We describe the strategies used by expert clinicians to continually manage care for a high proportion of patients with complex care needs. Although expert clinicians have developed effective workarounds, they experience significant moral distress when these strategies are unable to compensate for health system limitations. Practice Implications A better understanding of how clinicians manage the needs of patients with complex care needs could support policymakers and organizational leaders to consider macro- and meso-level strategies to support the adaptive practices of clinicians.
Article
Full-text available
Este trabalho teve como objetivo realizar uma revisão da literatura sobre a epidemiologia clínica: definição, importância e aplicação. Foram realizadas buscas no Pubmed, Google Acadêmico, e também em fontes de literaturas encontradas. Para a busca bibliográfica foram utilizadas as seguintes palavras-chave “epidemiologia clínica”, “clinical epidemiology”, “estudo de coorte” e “caso-controle”. A epidemiologia clínica é uma disciplina que integra métodos da epidemiologia tradicional à prática clínica, com o objetivo de melhorar o diagnóstico, tratamento e prognóstico das doenças. Ela utiliza ferramentas estatísticas e epidemiológicas para fundamentar decisões médicas, promovendo uma prática baseada em evidências. Sua aplicação abrange desde a formulação de diretrizes e avaliação de intervenções até a investigação de surtos e análise de dados de saúde. Além de impactar a saúde humana, também é amplamente utilizada na medicina veterinária, contribuindo para tomada de decisão e elucidação de fatores de risco para a prevenção e controle de doenças em populações animais. A epidemiologia clínica é essencial para a melhoria contínua da qualidade dos cuidados de saúde, tanto em contextos individuais, quanto populacionais.
Article
Alle paar Jahre kommen neue Konzepte und Trends auf, die versprechen, die Jahrzehnte alten Probleme in der Organisation des Gesundheits- und Sozialwesens zu lösen. Seit Kurzem steht Population Health Management (PHM) ganz oben auf der Agenda, ein Ansatz, der die Fortschritte in Big Data Analysen und prädiktiver Modellierung mit bereits etablierten Konzepten kombiniert, und diese als Ausgangspunkt für die Planung und Umsetzung von regionalen Gesundheits- und Sozialsystemen nimmt.
Article
Introduction: Social workers play a critical role in healthcare settings by addressing both medical and nonmedical needs. Trained in human behavior and social environments, they are best suited to screen for social determinants of health (SDOH) and connect patients with resources paving the way for optimal health and well-being. Methods: This narrative review synthesizes the existing literature on SDOH screening practices within healthcare settings, emphasizing the role of social workers. A systematic search was conducted across multiple databases. A total of 26 studies met the inclusion criteria and were analyzed using a qualitative narrative synthesis approach. Results: This review reveals variability in SDOH screening domains, tools, and implementation strategies across healthcare settings. Facilitators and barriers to implementation were identified, including workflow integration, interprofessional collaboration, and contextual readiness. Social workers emerged as key professionals in addressing health-related social risks, leveraging their expertise in patient engagement, assessment, and system navigation. We further introduced the integrated-Promoting Action on Research Implementation in Health Services (i-PARIHS) framework to suggest the effective integration of SDOH screenings, emphasizing innovation, recipient engagement, contextual readiness, and facilitation. Conclusion: The effective integration of SDOH screenings requires structured workflows, interdisciplinary collaboration, and policy support. The review provides practice models of workflows for SDOH screenings and implications within two different healthcare settings: hospitals and outpatient clinics, offering insights into best practices and areas for future research. Strengthening the role of social workers in SDOH screenings can improve patient outcomes and promote health equity.
Article
Health care providers participating in five accountable care organization (ACO) models designed, implemented, and evaluated by the Innovation Center at the Centers for Medicare & Medicaid Services have cared for almost six million fee-for-service Medicare patients over the past decade. This systematic review summarizes the features and performance of these ACO models, capturing five major themes arising from their evaluation reports: spending performance by ACO organization type; the role of management companies in ACO structure and performance; financial risk and ACO participation; clinician incentives, waivers, and payment mechanisms; and patient engagement with ACOs. In difference-in-differences analyses, these 214 ACOs lowered spending by an estimated 2.8billion,or2.8 billion, or 316.9 million after accounting for shared savings payouts derived from benchmarks, with no evident decrements in quality of care. ACOs’ challenge in ongoing and future ACO models is to apply their accrued experience to reduce spending and improve quality within a fee-for-service payment system.
Article
Policy Points Antitrust enforcement has been too narrowly focused on predicting postmerger market share and not enough on the likely impact of mergers and acquisitions on production efficiency and quality. Care delivery redesign is a term that captures various innovations and changes in the organization and delivery of health care, which may lead to increased production efficiency and improved quality of care. Regulators and policymakers can use the framework to develop empirical measures to assist in understanding changes in production processes as well as in resultant outcomes. Significant opportunities exist to improve data collection and require reporting to better assist regulators with antitrust enforcement and help policymakers create effective legislation. Examples include improving compliance with required hospital and insurer transaction price data reporting, growing the availability of all‐payer claims databases, improving existing Medicare cost reporting, and achieving consensus on quality measures that are best used to measure the impact of consolidation. There is a fundamental need to systematically track health care organizations and their affiliations and component parts (e.g., hospitals, physician practices, skilled nursing facilities, etc.) longitudinally, especially as organizations expand across markets and state boundaries and are owned by various entities, including private equity.
Article
Full-text available
To identify and quantify the major external (nongenetic) factors that contribute to death in the United States. Articles published between 1977 and 1993 were identified through MEDLINE searches, reference citations, and expert consultation. Government reports and complications of vital statistics and surveillance data were also obtained. Sources selected were those that were often cited and those that indicated a quantitative assessment of the relative contributions of various factors to mortality and morbidity. Data used were those for which specific methodological assumptions were stated. A table quantifying the contributions of leading factors was constructed using actual counts, generally accepted estimates, and calculated estimates that were developed by summing various individual estimates and correcting to avoid double counting. For the factors of greatest complexity and uncertainty (diet and activity patterns and toxic agents), a conservative approach was taken by choosing the lower boundaries of the various estimates. The most prominent contributors to mortality in the United States in 1990 were tobacco (an estimated 400,000 deaths), diet and activity patterns (300,000), alcohol (100,000), microbial agents (90,000), toxic agents (60,000), firearms (35,000), sexual behavior (30,000), motor vehicles (25,000), and illicit use of drugs (20,000). Socioeconomic status and access to medical care are also important contributors, but difficult to quantify independent of the other factors cited. Because the studies reviewed used different approaches to derive estimates, the stated numbers should be viewed as first approximations. Approximately half of all deaths that occurred in 1990 could be attributed to the factors identified. Although no attempt was made to further quantify the impact of these factors on morbidity and quality of life, the public health burden they impose is considerable and offers guidance for shaping health policy priorities.
Article
Full-text available
The health implications of regional differences in Medicare spending are unknown. To determine whether regions with higher Medicare spending achieve better survival, functional status, or satisfaction with care. Cohort study. National study of Medicare beneficiaries. Patients hospitalized between 1993 and 1995 for hip fracture (n = 614,503), colorectal cancer (n = 195,429), or acute myocardial infarction (n = 159,393) and a representative sample (n = 18,190) drawn from the Medicare Current Beneficiary Survey (MCBS) (1992-1995). EXPOSURE MEASUREMENT: End-of-life spending reflects the component of regional variation in Medicare spending that is unrelated to regional differences in illness. Each cohort member's exposure to different levels of spending was therefore defined by the level of end-of-life spending in his or her hospital referral region of residence (n = 306). 5-year mortality rate (all four cohorts), change in functional status (MCBS cohort), and satisfaction (MCBS cohort). Cohort members were similar in baseline health status, but those in regions with higher end-of-life spending received 60% more care. Each 10% increase in regional end-of-life spending was associated with the following relative risks for death: hip fracture cohort, 1.003 (95% CI, 0.999 to 1.006); colorectal cancer cohort, 1.012 (CI, 1.004 to 1.019); acute myocardial infarction cohort, 1.007 (CI, 1.001 to 1.014); and MCBS cohort, 1.01 (CI, 0.99 to 1.03). There were no differences in the rate of decline in functional status across spending levels and no consistent differences in satisfaction. Medicare enrollees in higher-spending regions receive more care than those in lower-spending regions but do not have better health outcomes or satisfaction with care. Efforts to reduce spending should proceed with caution, but policies to better manage further spending growth are warranted.
Article
Full-text available
The health implications of regional differences in Medicare spending are unknown. To determine whether regions with higher Medicare spending provide better care. Cohort study. National study of Medicare beneficiaries. Patients hospitalized between 1993 and 1995 for hip fracture (n = 614,503), colorectal cancer (n = 195,429), or acute myocardial infarction (n = 159,393) and a representative sample (n = 18,190) drawn from the Medicare Current Beneficiary Survey (1992-1995). EXPOSURE MEASUREMENT: End-of-life spending reflects the component of regional variation in Medicare spending that is unrelated to regional differences in illness. Each cohort member's exposure to different levels of spending was therefore defined by the level of end-of-life spending in his or her hospital referral region of residence (n = 306). Content of care (for example, frequency and type of services received), quality of care (for example, use of aspirin after acute myocardial infarction, influenza immunization), and access to care (for example, having a usual source of care). Average baseline health status of cohort members was similar across regions of differing spending levels, but patients in higher-spending regions received approximately 60% more care. The increased utilization was explained by more frequent physician visits, especially in the inpatient setting (rate ratios in the highest vs. the lowest quintile of hospital referral regions were 2.13 [95% CI, 2.12 to 2.14] for inpatient visits and 2.36 [CI, 2.33 to 2.39] for new inpatient consultations), more frequent tests and minor (but not major) procedures, and increased use of specialists and hospitals (rate ratio in the highest vs. the lowest quintile was 1.52 [CI, 1.50 to 1.54] for inpatient days and 1.55 [CI, 1.50 to 1.60] for intensive care unit days). Quality of care in higher-spending regions was no better on most measures and was worse for several preventive care measures. Access to care in higher-spending regions was also no better or worse. Regional differences in Medicare spending are largely explained by the more inpatient-based and specialist-oriented pattern of practice observed in high-spending regions. Neither quality of care nor access to care appear to be better for Medicare enrollees in higher-spending regions.
Article
Background: Congestive heart failure is the most common discharge diagnosis for Medicare beneficiaries. While several single-center studies have suggested that these patients are particularly vulnerable to readmission, no recent study, to our knowledge, has reported the readmission rates for a large number of elderly patients with congestive heart failure across a diverse spectrum of hospitals. Objectives: To define the readmission rate for elderly patients discharged after an episode of congestive heart failure. To determine the spectrum of diagnoses that are responsible for readmissions among patients with congestive heart failure. To identify patient and hospital characteristics associated with a higher likelihood of readmission. Methods: This observational study, using Medicare administrative files, evaluated readmission and death among all survivors of a hospitalization in Connecticut for congestive heart failure from fiscal year 1991 through fiscal year 1994. Results: There were 17448 survivors of a hospitalization for congestive heart failure during the study period. In the 6 months following the index admission, 7596 patients (44%) were readmitted to a hospital at least once. Congestive heart failure was the most frequent reason for readmission among study patients, accounting for 18% of all readmissions. In the multivariable analysis, significant predictors of readmission included male sex (odds ratio [OR], 1.12; 95% confidence interval [CI], 1.05-1.20), at least 1 prior admission within 6 months of the index admission (OR, 1.64; 95% CI, 1.53-1.77), Deyo comorbidity score of more than 1 (OR, 1.56; 95% CI, 1.45-1.68), and length of stay in the index hospitalization of more than 7 days (OR, 1.32; 95% CI, 1.24-1.41). While age was not a significant predictor of readmission, it became significant in a model with the combined outcome of readmission or death as the dependent variable. Conclusion: Readmission after a hospitalization for congestive heart failure is common among Medicare beneficiaries, with almost half of the patients readmitted within 6 months. This striking rate of readmission in a common diagnosis demands efforts to further clarify the determinants of readmission and develop strategies to prevent this adverse outcome.Arch Intern Med. 1997;157:99-104
Article
The resources for medical care are clearly finite, but demands on those resources are growing rapidly. Of particular concern are the demands on those resources for medical practices of three kinds: those that pose conflicts between the interests of the individual and those of society; those of no value or of undetermined value; and those for potentially preventable conditions. Such practices must be evaluated in terms of social and medical priorities, and this requirement will become more urgent with the establishment of national health insurance. Who will make decisions is less clear, but it is not likely to be physicians alone. It is imperative that physicians and other health providers work closely with professionals from many fields, and with consumers, to ensure the availability and dissemination of information that will permit decisions that are in the best interests of society.
Article
Congestive heart failure is the most common discharge diagnosis for Medicare beneficiaries. While several single-center studies have suggested that these patients are particularly vulnerable to readmission, no recent study, to our knowledge, has reported the readmission rates for a large number of elderly patients with congestive heart failure across a diverse spectrum of hospitals. To define the readmission rate for elderly patients discharged after an episode of congestive heart failure. To determine the spectrum of diagnoses that are responsible for readmissions among patients with congestive heart failure. To identify patient and hospital characteristics associated with a higher likelihood of readmission. This observational study, using Medicare administrative files, evaluated readmission and death among all survivors of a hospitalization in Connecticut for congestive heart failure from fiscal year 1991 through fiscal year 1994. There were 17448 survivors of a hospitalization for congestive heart failure during the study period. In the 6 months following the index admission, 7596 patients (44%) were readmitted to a hospital at least once. Congestive heart failure was the most frequent reason for readmission among study patients, accounting for 18% of all readmissions. In the multivariable analysis, significant predictors of readmission included male sex (odds ratio [OR], 1.12; 95% confidence interval [CI], 1.05-1.20), at least 1 prior admission within 6 months of the index admission (OR, 1.64; 95% CI, 1.53-1.77), Deyo comorbidity score of more than 1 (OR, 1.56; 95% CI, 1.45-1.68), and length of stay in the index hospitalization of more than 7 days (OR, 1.32; 95% CI, 1.24-1.41). While age was not a significant predictor of readmission, it became significant in a model with the combined outcome of readmission or death as the dependent variable. Readmission after a hospitalization for congestive heart failure is common among Medicare beneficiaries, with almost half of the patients readmitted within 6 months. This striking rate of readmission in a common diagnosis demands efforts to further clarify the determinants of readmission and develop strategies to prevent this adverse outcome.
Article
To assess the impact of a comprehensive heart failure management program, functional status, hospital readmission rate and estimated hospital costs were determined and compared for the 6 months before and the 6 months after referral. The course of advanced heart failure is characterized by progressive clinical deterioration reflected in frequent hospital admissions, which comprise the major financial cost. Over a 3-year period, 214 patients were accepted for heart transplantation and discharged after evaluation, which included adjustments in medical therapy and intensive patient education. Patients were in New York Heart Association functional class III or IV (94 and 120 patients, respectively), with a mean left ventricular ejection fraction of 0.21, peak oxygen consumption of 11 ml/kg per min and a total of 429 hospital admissions in the previous 6 months (average 2.0 per patient). Changes in the medical regimen included a 98% increase in angiotensin-converting enzyme inhibitor dose and a flexible diuretic regimen after 4.2-liter net diuresis, with counseling also regarding diet and progressive exercise. During the 6 months after referral, there were only 63 hospital readmissions (85% reduction), with 0.29/patient (p < 0.0001). Functional status improved as assessed by functional class (p < 0.0001) and peak oxygen consumption (15.2 vs. 11.0 ml/kg per min, p < 0.001). The same results were seen after excluding the 35 patients without full 6-month follow-up (9 deaths, 14 urgent transplant procedures during hospital readmission, 12 elective transplant procedures from home); 34 hospital admissions occurred after referral, compared with 344 before referral. Even when adding in the initial hospital admission after referral for these 179 patients, there was a 35% decrease in total hospital admissions in the 6-month period. The estimated savings in hospital readmission costs after subtracting the initial hospital costs for management was $9,800 per patient. Comprehensive heart failure management led to improved functional status and an 85% decrease in the hospital admission rate for transplant candidates discharged after evaluation. The potential to reduce both symptoms and costs suggests that referral to a heart failure program may be appropriate not only for potential heart transplantation, but also for medical management of persistent functional class III and IV heart failure.